Skip to content
Biodatica
Start free

Investigator

Wilbur A Lam

EMORY UNIVERSITY · funded by NIBIB, NHLBI

Companies
2

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$3.8M

Summed across those awards.

First award
Sep 18, 2018

Latest Jun 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. T32

    Advancement of Diagnostics by Joining User-centered and Scalable Technologies - Training Program (ADJUST TP)

    $108k

    Jun 1, 2025NIBIBEMORY UNIVERSITYNIH RePORTER · 11096586 (opens the source filing in a new tab)

  2. T32

    Advancement of Diagnostics by Joining User-centered and Scalable Technologies - Training Program (ADJUST TP)

    $220k

    Jun 1, 2025NIBIBEMORY UNIVERSITYNIH RePORTER · 11362171 (opens the source filing in a new tab)

  3. R35

    Engineering biophysical microtechnologies for hematologic applications in health and disease

    $775k

    Mar 22, 2019NHLBIEMORY UNIVERSITYNIH RePORTER · 11045002 (opens the source filing in a new tab)

  4. U54

    Administrative Core

    $192k

    Sep 18, 2018NIBIBEMORY UNIVERSITYNIH RePORTER · 11177727 (opens the source filing in a new tab)

  5. U54

    Technology Core

    $959k

    Sep 18, 2018NIBIBEMORY UNIVERSITYNIH RePORTER · 11177733 (opens the source filing in a new tab)

  6. U54

    Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT)

    $1.6M

    Sep 18, 2018NIBIBEMORY UNIVERSITYNIH RePORTER · 11177705 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources